NCT06274008View on ClinicalTrials.gov

Exparel vs. ACB With Bupivacaine for ACL Reconstruction

PHASE1RecruitingINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

October 30, 2024

Study Completion Date

December 31, 2024

Conditions
ACL TearOpioid MisusePainAnxiety
Interventions
DRUG

Exparel

Admixture bupivacaine 0.5 % 10 cc with Bupivacaine Liposome Injectable Suspension 10cc total 20

Trial Locations (1)

92868

RECRUITING

CHOC Children's Hospital, Orange

All Listed Sponsors
lead

Children's Hospital of Orange County

OTHER